HAOHAI BIOTEC (06826.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec26

Haohai Bio-Pharmaceutical CEO Fined Nearly $2 Million for Insider Trading

09:52

Dec22

Haohai Biotechnology repurchased 17,000 shares for HKD 434,900

09:13

Dec18

Tang Minjie 增持 Haus Health 10,000 股

12:45

Dec17

Hao Hai Bio-Technology repurchased 91,700 shares

09:41

Dec15

Haohai Bio-Technology Acquires 22.26% Equity of Jiangxi Ruiji Biotechnology

00:50

Dec12

Hao Hai Biotechnology and Zhong Xiaoyan Plan to Acquire Equity in Jiangxi Ruiji Bioengineering

12:35

Schedules & Filings

Schedules

Filings

Oct24

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 650.09 M, Net Income 102.3 M, EPS 0.4375

Oct17

Distribution Plan(CST)

Cash dividend 0.4384 HKD

Sep8

Distribution Plan(CST)

Cash dividend 0.4384 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More